QC
BLUE

QCM Cayman’s bluebird bio BLUE Stock Holding History

QCM Cayman’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-186
Closed -$239K – 46
2018
Q4 		$239K Sell
186
-6
-3% -$9.2K 0.98% 40
2018
Q3 		$362K Buy
+192
New +$397K 1.19% 23
2016
Q2 		– Sell
-465
Closed -$256K – 291
2016
Q1 		$256K Buy
465
+107
+30% +$65.7K 0.17% 103
2015
Q4 		$298K Buy
+358
New +$358K 0.25% 66

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QCM Cayman's BLUE Position: Q1 2019 in Review

QCM Cayman sold out of bluebird bio (BLUE) in Q1 2019, closing a stake of 186 shares — an estimated $239K sold.

QCM Cayman first reported a position in BLUE in Q4 2015 and held it in 4 quarters. The position peaked at $362K in Q3 2018. 288 funds tracked by Wall St. Rank hold BLUE as of Q1 2019.

  • QCM Cayman reported no remaining bluebird bio position as of Q1 2019 after selling out during the quarter.
  • QCM Cayman sold 186 bluebird bio shares in Q1 2019, an estimated $239K.
  • QCM Cayman first reported a position in bluebird bio in Q4 2015 and held it in 4 quarters.
  • QCM Cayman's bluebird bio position peaked at $362K in Q3 2018.
  • 288 funds tracked by Wall St. Rank held bluebird bio as of Q1 2019.

Based on QCM Cayman's 13F filing for Q1 2019, filed 13 May 2019.